JHS Svendgaard Laboratories Share Price Today | Stock Price & JHS Svendgaard Laboratories Share Screener
As of October 1, 2026, the live JHS Svendgaard Laboratories share price (NSE: JHS) is ₹11.70 on NSE and ₹10.63 on BSE, down 6.02% from the previous close, with shares trading between ₹11.22 and ₹13.69 in today's trading session, and a 52-week range of ₹6.55–₹13.56. Check JHS yearly price range for the annual price range and momentum. Use the JHS Svendgaard Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today JHS Svendgaard Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹31 and net income of ₹1, with EBITDA of ₹2, an operating margin of 7.0% and a profit margin of 3.2%.
JHS Svendgaard Laboratories Share Price Chart
Track the current stock price of JHS Svendgaard Laboratories with an interactive chart. Analyse JHS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete JHS Svendgaard Laboratories stock quote in one place.
The quote of ₹11.70 sits between the 52-week low of ₹6.55 and the 52-week high of ₹13.56, and the latest session moved -6.02% from the previous close.
JHS Svendgaard Laboratories Company Profile - Fundamental Screener
Screen JHS Svendgaard Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JHS shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Consumer Goods sector and the Personal Care industry, and it trades under ISIN INE544H01014.
Company Details
Classification
Identifiers and Leadership
JHS Svendgaard Laboratories Balance Sheet Screener
Screen JHS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹215, up from ₹201 in 2025.
Latest statistics put total assets at ₹215 and shareholder funds at ₹175, with a leverage ratio of 0.06.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 215 | 201 | 197 | 228 | 222 | 228 | 241 | 221 | 208 | 155 |
| Current Assets | 63 | 53 | 44 | 85 | 79 | 121 | 130 | 102 | 103 | 43 |
| Fixed Assets | 89 | 90 | 90 | 65 | 59 | 63 | 66 | 71 | 71 | 65 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 8 | 4 | 4 | 18 | 8 | 7 | 8 | 2 | 2 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 175 | 173 | 170 | 174 | 195 | 198 | 185 | 181 | 174 | 134 |
| Share Capital | 87 | 86 | 78 | 78 | 65 | 64 | 61 | 61 | 61 | 44 |
| Reserves & Surplus | 87 | 85 | 92 | 95 | 121 | 124 | 117 | 116 | 113 | 86 |
JHS Svendgaard Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen JHS Svendgaard Laboratories income statement and profit fundamentals. Analyze JHS quarterly results. JHS Svendgaard Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹31 and net profit was ₹1, equal to earnings per unit of ₹0.12, at an operating margin of 7%.
In that period expenses were ₹28, interest cost ₹0 and tax ₹-1. The next period listed, 2026-Mar, shows revenue of ₹33 and net profit of ₹-4.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 31 | 33 | 24 | 23 | 25 | 27 | 23 | 21 | 25 | 23 | 17 | 19 | 16 | 29 | 23 |
| Expenses | 28 | 34 | 22 | 21 | 22 | 33 | 22 | 21 | 23 | 21 | 14 | 19 | 18 | 44 | 24 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 2 | -1 | 2 | 2 | 3 | -7 | 1 | 0 | 2 | 2 | 2 | 1 | -2 | -15 | -1 |
| Operating Profit % | 7.00% | -5.00% | 7.00% | 4.00% | 7.00% | -33.00% | 1.00% | -4.00% | 8.00% | 4.00% | 0.00% | 2.00% | -13.00% | -102.00% | -10.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 0 | -3 | 0 | 0 | 1 | -9 | -2 | -2 | 0 | 0 | 1 | -1 | -3 | -17 | -3 |
| Tax | -1 | 1 | -1 | 0 | 0 | -2 | 0 | 8 | 1 | 1 | 1 | 0 | -1 | -6 | 0 |
| Net Profit | 1 | -4 | 1 | 0 | 1 | -7 | -2 | -10 | -1 | -1 | 0 | -1 | -3 | -11 | -3 |
| EPS | 0.12 | -0.42 | 0.09 | -0.02 | 0.12 | -0.84 | -0.21 | -1.24 | -0.08 | -0.10 | 0.00 | -0.09 | -0.33 | -1.37 | -0.24 |
JHS Svendgaard Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen JHS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹3, and net cash flow was an outflow of ₹3.
Over the same period, investing activities used ₹12 and financing activities provided ₹11.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -3 | -5 | -9 | 23 | -9 | 12 | 10 | -11 | 14 | -4 |
| Investing Activities | -12 | -20 | -21 | 10 | -5 | -2 | -11 | -7 | -27 | -3 |
Financing and Net Cash | ||||||||||
| Financing Activities | 11 | 23 | 2 | -1 | -2 | 10 | 1 | 13 | 14 | 10 |
| Net Cash Flow | -3 | -2 | -28 | 32 | -16 | 20 | 0 | -5 | 0 | 3 |
JHS Svendgaard Laboratories Shareholding Pattern Screener
See JHS Svendgaard Laboratories shareholding pattern with promoter, FII, and DII holdings. Check JHS Svendgaard Laboratories promoter holding and ownership changes for JHS on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Feb, promoters held 33.85%, foreign institutions 3.60%, domestic institutions 0.00% and the public 46.63%, spread across 25,377 shareholders.
The shareholder count was 25,377 in 2026-Feb, compared with 25,330 in 2026-Mar.
| Item | 2026-Feb | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 33.85% | 33.85% | 33.85% | 34.56% | 34.56% | 34.56% | 34.56% | 37.73% |
Institutional Investors | ||||||||
| FII Holding | 3.60% | 3.60% | 3.14% | 1.60% | 1.59% | 1.57% | 1.57% | 2.30% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.21% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 46.63% | 46.61% | 47.48% | 46.91% | 47.00% | 47.30% | 47.59% | 42.75% |
| Other Holding | 15.93% | 15.94% | 15.53% | 16.93% | 16.85% | 16.57% | 16.29% | 11.02% |
| Shareholder Count | 25,377 | 25,330 | 25,150 | 25,567 | 25,155 | 25,007 | 25,151 | 26,448 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by JHS Svendgaard Laboratories. JHS Svendgaard Laboratories dividend yield can be compared with peers and other stocks in the market.
JHS Svendgaard Laboratories Stock Index Membership - Nifty & Sensex
See which indices include JHS Svendgaard Laboratories stock. Check JHS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
JHS Svendgaard Laboratories Market Events Screener - Corporate Actions
Get JHS Svendgaard Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check JHS Svendgaard Laboratories stock events that may affect JHS share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 26, 2026, with a record date of September 26, 2026.
It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 26, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-26 | 2026-09-26 | Annual General Meeting | NA | 1.91% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 2.58% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 0.70% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | -1.42% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -7.53% |
| 2025-09-20 | 2025-09-20 | Annual General Meeting | NA | 6.07% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 2.70% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -0.50% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -6.08% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -7.49% |
| 2024-09-10 | 2024-09-10 | Annual General Meeting | NA | 37.29% |
| 2024-07-04 | 2024-07-04 | Extraordinary General Meeting | NA | 7.82% |
JHS Svendgaard Laboratories Competitors Screener - Peer Stocks Comparison
Screen JHS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Consumer Goods sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Godrej Consumer Products | 85,651 | 45.08 | 15,444 | 7.90% | 1,862 | 28.30 |
| Dabur India | 67,171 | 34.37 | 13,792 | 5.18% | 1,869 | 41.21 |
| Colgate Palmolive | 48,277 | 35.02 | 6,124 | -0.89% | 1,325 | 39.30 |
| Cupid | 41,698 | 306.76 | 391 | 92.62% | 108 | 65.52 |
| Gillette | 22,741 | 33.67 | 3,127 | 38.21% | 654 | 37.31 |
| P&G Hygiene and Health Care | 21,969 | 27.29 | 4,333 | 27.00% | 857 | 20.18 |
| Emami | 16,489 | 21.67 | 3,865 | -0.33% | 775 | 46.78 |
| Mamaearth | 14,414 | 55.95 | 2,476 | 15.37% | 200 | 41.29 |
| Bajaj Consumer Care | 6,274 | 29.12 | 1,192 | 19.13% | 190 | 40.70 |
| Anondita Medicare | 1,964 | 59.89 | 138 | 79.38% | 34 | 38.78 |
JHS Svendgaard Laboratories Company Announcements - News & Reports Screener
Screen JHS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 30, 2026.
The next most recent announcements are dated September 27, 2026 and September 21, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-27 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-21 | Closure of Trading Window | - |
| 2026-09-17 | Letter To Shareholders | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-02 | Notice Of 22Nd Annual General Meeting | - |
| 2026-09-02 | Reg. 34 (1) Annual Report. | - |
| 2026-08-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Statement Of Deviation & Variation | - |
| 2026-08-11 | Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-11 | Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-05 | Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 30 June 2026 | - |
| 2026-07-31 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-07-29 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-29 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-06-24 | Closure of Trading Window | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹11.70, within a 52-week range of ₹6.55 to ₹13.56. The P/E ratio is -53.68 and the P/B ratio is 0.59, with earnings per unit of ₹-0.22. Market capitalisation stands at ₹92.04 Cr. The company operates in the Consumer Goods sector, in the Personal Care industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.